Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
In its 3Q12 earnings ending Dec. 31, 2012, Dainippon said it began a double-blind, placebo-controlled, Japanese Phase II trial to evaluate oral DSP-6952 in about 165 patients. ...